Trials / Completed
CompletedNCT02073084
A Thorough Corrected QT Interval Trial
- Status
- Completed
- Phase
- Phase 1
- Study type
- Interventional
- Enrollment
- 56 (actual)
- Sponsor
- Kowa Research Institute, Inc. · Industry
- Sex
- All
- Age
- 18 Years – 45 Years
- Healthy volunteers
- Accepted
Summary
The purpose of this study is to determine the effects of K-877 on ECG parameters with a focus on cardiac repolarization compared with placebo in healthy adult subjects.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | K-877 Low Dose | K-877 Low Dose |
| DRUG | Moxifloxacin | |
| OTHER | Placebo | |
| DRUG | K-877 High Dose | K-877 High Dose |
Timeline
- Start date
- 2014-01-01
- Primary completion
- 2014-03-01
- First posted
- 2014-02-27
- Last updated
- 2015-04-10
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT02073084. Inclusion in this directory is not an endorsement.